February 4, 2020 / 10:24 PM / 12 days ago

U.S. FDA expands use of CDC coronavirus diagnostic test

Feb 4 (Reuters) - The U.S. Food and Drug Administration on Tuesday extended the use of a coronavirus detection tool to Centers for Disease Control and Prevention (CDC)-qualified laboratories across the country.

The authorization was until recently limited to CDC laboratories.

Under the emergency use authorization, the 2019-nCoV Real-Time RT-PCR diagnostic panel can be used in patients who meet the CDC criteria for coronavirus testing.

“Negative results do not preclude 2019-nCoV infection and should not be used as the sole basis for treatment or other patient management decisions,” the FDA said.

Reporting by Dania Nadeem in Bengaluru; Editing by Shinjini Ganguli

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below